GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 137 filers reported holding GENOMIC HEALTH INC in Q4 2017. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $2,705,000 | -37.7% | 39,889 | -46.6% | 0.02% | -26.7% |
Q2 2019 | $4,345,000 | +1680.7% | 74,687 | +2041.3% | 0.03% | +1400.0% |
Q1 2019 | $244,000 | -57.6% | 3,488 | -61.0% | 0.00% | -60.0% |
Q4 2018 | $576,000 | +59.6% | 8,944 | +74.1% | 0.01% | +66.7% |
Q3 2018 | $361,000 | +122.8% | 5,137 | +59.9% | 0.00% | +200.0% |
Q2 2018 | $162,000 | -42.3% | 3,212 | -63.4% | 0.00% | -50.0% |
Q3 2017 | $281,000 | +41.2% | 8,769 | +43.2% | 0.00% | 0.0% |
Q2 2017 | $199,000 | +42.1% | 6,122 | +37.8% | 0.00% | +100.0% |
Q1 2017 | $140,000 | -61.2% | 4,443 | -63.9% | 0.00% | -66.7% |
Q4 2016 | $361,000 | +51.0% | 12,299 | +8.8% | 0.00% | +200.0% |
Q3 2015 | $239,000 | +25.1% | 11,302 | +89.2% | 0.00% | 0.0% |
Q4 2014 | $191,000 | +42.5% | 5,972 | +21.9% | 0.00% | 0.0% |
Q2 2014 | $134,000 | -69.4% | 4,899 | -67.3% | 0.00% | -50.0% |
Q4 2013 | $438,000 | -14.5% | 14,960 | -10.7% | 0.00% | 0.0% |
Q3 2013 | $512,000 | +86.2% | 16,752 | +93.4% | 0.00% | +100.0% |
Q2 2013 | $275,000 | – | 8,664 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 13,770,982 | $433,648,000 | 3.55% |
Camber Capital Management LP | 2,458,100 | $77,406,000 | 3.14% |
EMORY UNIVERSITY | 76,851 | $2,420,000 | 2.28% |
Tributary Capital Management, LLC | 294,962 | $9,288,000 | 0.91% |
Motley Fool Asset Management LLC | 131,935 | $4,155,000 | 0.90% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,607,649 | $50,625,000 | 0.71% |
UNIVERSITY OF NOTRE DAME DU LAC | 79,693 | $2,510,000 | 0.63% |
Motley Fool Wealth Management, LLC | 129,245 | $4,070,000 | 0.39% |
Spark Investment Management LLC | 189,700 | $5,973,000 | 0.38% |
TFS CAPITAL LLC | 35,026 | $1,103,000 | 0.36% |